Tholpady Sunil S, Ogle Roy C, Katz Adam J
Department of Plastic and Reconstructive Surgery, University of Virginia, Health Sciences Center, Charlottesville, Virginia, USA.
Curr Opin Organ Transplant. 2009 Feb;14(1):51-5. doi: 10.1097/MOT.0b013e328320d2cf.
This review will cover the basic research performed with adipose stem cells (ASCs) over the past several years as well as pertinent translational research. The properties of ASCs that make them particularly interesting to the transplant surgeon will then be covered. These properties include regeneration of native tissue, support of microvasculature, and immunomodulation. These properties will undoubtedly expand the future utility of these cells.
Recent literature demonstrates that ASCs are able to differentiate into phenotypes resembling hepatic and pancreatic lineages. In addition, several groups have shown that ASCs possess immunomodulatory properties similar to bone marrow-derived mesenchymal stem cells. Several clinical case reports also suggest that ASCs are an effective treatment option for graft-versus-host disease.
Due to their ability to differentiate into pertinent target lineages, their ability to enhance angiogenesis, and their ability to impact immunologic responses, ASCs may prove clinically useful for the transplant surgeon.
本综述将涵盖过去几年对脂肪干细胞(ASC)进行的基础研究以及相关的转化研究。随后将阐述使移植外科医生对ASC特别感兴趣的特性。这些特性包括天然组织的再生、微血管支持和免疫调节。这些特性无疑将拓展这些细胞未来的应用。
近期文献表明,ASC能够分化为类似肝系和胰腺系的表型。此外,多个研究小组已表明,ASC具有与骨髓间充质干细胞相似的免疫调节特性。一些临床病例报告也提示,ASC是移植物抗宿主病的一种有效治疗选择。
由于ASC具有分化为相关靶细胞系的能力、增强血管生成的能力以及影响免疫反应的能力,它们可能对移植外科医生具有临床应用价值。